It is better to be in a clinical trial than not: lessons learnt from clinical neurology—the management of acute multiple sclerosis relapses

N. McNicholas12 A. Patel1 and J. Chataway13

首页> 外文期刊>QJM >It is better to be in a clinical trial than not: lessons learnt from clinical neurology—the management of acute multiple sclerosis relapses

【24h】

It is better to be in a clinical trial than not: lessons learnt from clinical neurology—the management of acute multiple sclerosis relapses

机译：进行临床试验总比没有好：从临床神经病学中汲取的教训-急性多发性硬化症复发的管理

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objective: To compare being on-, or off-, a randomized controlled trial (RCT) for the same intervention.

机译：目的：比较随机或随机对照试验（RCT）对同一干预措施的影响。

著录项

来源
《QJM》 |2012年第8期|p.775-780|共6页
作者
N. McNicholas12 A. Patel1 and J. Chataway13;
展开▼
作者单位

From the 1National Hospital for Neurology and Neurosurgery, University College London Hospitals NHS Foundation Trust, Queen Square, London WC1N 3BG, UK, 2School of Medicine and Medical Science, University College Dublin, Dublin, Ireland and 3Department of Neuroinflammation, Institute of Neurology, University College, London, WC1N 3BG, UK;

展开▼
收录信息美国《科学引文索引》(SCI);美国《化学文摘》(CA);
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Ethical Challenges in Cell-Based Interventions for Neurological Conditions: Some Lessons To Be Learnt from Clinical Transplantation Trials in Patients with Parkinson's Disease [J] . Hildt E American journal of bioethics . 2009,第5期

机译：基于细胞的神经疾病干预中的伦理挑战：帕金森氏病患者临床移植试验的一些教训
2. Progressive multiple sclerosis 3 Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives [J] . Ontaneda Daniel, Fox Robert J., Chataway Jeremy Lancet Neurology . 2015,第2期

机译：进行性多发性硬化症3进行性多发性硬化症的临床试验：经验教训和未来展望
3. A MULTICENTRE, RANDOMIZED, DOUBLE-BLIND, NON-INFERIORITY CLINICAL TRIAL TO COMPARE THE CLINICAL AND RADIOLOGICAL EFFICACY OF 625 VS. 1250 MG OF ORAL METHYLPREDNISOLONE IN PATIENTS WITH RELAPSE OF MULTIPLE SCLEROSIS: THE ORAL-CORTEM TRIAL [J] . Torres F., Hervas-Garcia J. V, Pontes C., Basic & clinical pharmacology & toxicology. . 2016,第Suppla1期

机译：一项多中心，随机，双盲，非劣质性临床试验，以比较625 VS的临床和放射学疗效。多发性硬化症缓解的患者口服1250 MG甲基甲泼尼松龙：口服-口服试验
4. Lesion Detection, Segmentation and Prediction in Multiple Sclerosis Clinical Trials [C] . Andrew Doyle, Colm Elliott, Zahra Karimaghaloo, International workshop on brainlesion;International conference on medical imaging computing and computer-assisted intervention . 2018

机译：多发性硬化症临床试验中的病变检测，分割和预测
5. Development of potential biomarkers to forecast treatment response and clinical relapses of multiple sclerosis by investigating the CNS-specific proteome fingerprint of experimental autoimmune encephalomyelitis [D] . Raphael, Itay 2016

机译：通过研究实验性自身免疫性脑脊髓炎的中枢神经系统特异性蛋白质组指纹图谱，开发潜在的生物标记物以预测多发性硬化症的治疗反应和临床复发
6. Redefining Acute Relapses in Multiple Sclerosis: Implications for Phase 3 Clinical Trials and Treatment Algorithms [O] . Jagannadha Avasarala 2017

机译：重新定义多发性硬化症的急性复发：对3期临床试验和治疗算法的影响。
7. It is better to be in a clinical trial than not: lessons learnt from clinical neurology--the management of acute multiple sclerosis relapses [O] . N. McNicholas, A. Patel, J. Chataway 2012

机译：在临床试验中最好是不是：从临床神经内科吸取的经验教训 - 急性多发性硬化的管理复发

It is better to be in a clinical trial than not: lessons learnt from clinical neurology—the management of acute multiple sclerosis relapses

摘要

著录项

相似文献

相关主题

期刊订阅